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The Neural Cell Adhesion Molecule NCAM
Is an Alternative Signaling Receptor
for GDNF Family Ligands
p140NCAM isoform has been shown to associate constitu-
tively with Fyn, a member of the Src family of cyto-
plasmic tyrosine kinases (Beggs et al., 1997). Fyn be-
comes rapidly and transiently activated upon NCAM
ligation, leading to recruitment of the focal adhesion
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Retzius va¨g 8, A2:2 kinase FAK (Beggs et al., 1997), a nonreceptor tyrosine
kinase known to participate in cytoskeletal rear-17177 Stockholm
Sweden rangements. Increased protein tyrosine phosphatase
activity has also been observed upon NCAM activation
(Klinz et al., 1995). Other studies have shown that NCAM
is also able to transactivate the fibroblast growth factorSummary
receptor (FGFR) (Saffell et al., 1997; Williams et al., 1994).
The GDNF (glial cell line-derived neurotrophic factor)Intercellular communication involves either direct cell-
cell contact or release and uptake of diffusible signals, ligand family is a small group of neurotrophic growth
factors, representative of an important class of solubletwo strategies mediated by distinct and largely non-
overlapping sets of molecules. Here, we show that the mediators of neuronal survival, neuritic growth, and dif-
ferentiation (Airaksinen et al., 1999; Baloh et al., 2000).neural cell adhesion molecule NCAM can function as
a signaling receptor for members of the GDNF ligand Four members are known in the family including GDNF,
Neurturin (NTN), Persephin (PSP), and Artemin (ART).family. Association of NCAM with GFR1, a GPI-
anchored receptor for GDNF, downregulates NCAM- Intercellular signaling by members of this family is medi-
ated by a receptor complex formed by the RET receptormediated cell adhesion and promotes high-affinity
binding of GDNF to p140NCAM, resulting in rapid activa- tyrosine kinase and a ligand binding, GPI-anchored sub-
unit termed GDNF family receptor  (GFR) (Durbec ettion of cytoplasmic protein tyrosine kinases Fyn and
FAK in cells lacking RET, a known GDNF signaling al., 1996; Jing et al., 1996; Treanor et al., 1996; Trupp
et al., 1996). Activation of RET by GDNF family ligandsreceptor. GDNF stimulates Schwann cell migration
and axonal growth in hippocampal and cortical neu- requires the presence of distinct members (GFR1 to
4) of the GFR family (Airaksinen et al., 1999; Baloh etrons via binding to NCAM and activation of Fyn, but
independently of RET. These results uncover an unex- al., 2000). Throughout the nervous system and, particu-
larly in the forebrain, GFRs are much more widely ex-pected intersection between short- and long-range
mechanisms of intercellular communication and re- pressed than RET (Trupp et al., 1997; Yu et al., 1998),
suggesting that GFRs may signal independently ofveal a pathway for GDNF signaling that does not re-
quire the RET receptor. RET, presumably in collaboration with novel transmem-
brane proteins (Poteryaev et al., 1999; Trupp et al., 1999).
Despite its potential importance, the biological signifi-Introduction
cance of RET-independent signaling by GDNF family
ligands has not been established, and the existence ofDuring the development of the nervous system, short-
and long-range signals cooperate to promote neuronal additional GDNF receptors remains to be demonstrated.
In this work, we set out to investigate proximal eventssurvival, migration, differentiation, axonal growth, guid-
ance, and target innervation. While short-range signal- in RET-independent signaling by GDNF in neuronal and
glial cells and found a striking similarity with intracellularing involves direct contact between cells or with the
extracellular matrix, long-range signaling requires the pathways activated by the p140NCAM NCAM isoform. We
show that p140NCAM can interact directly with GDNF fam-release and diffusion of messenger molecules, which
are then sensed by specific receptors in distant target ily ligands and, with the aid of GFR receptors, mediate
GDNF signaling independently of the presence of RET.cells. This subdivision implies more than a mere concep-
tual classification, as short- and long-range intercellular The ability of GDNF to promote Schwann cell migration
and axonal growth in hippocampal and cortical neuronssignaling also involve distinct sets of cell surface mole-
cules coupled to different intracellular pathways. via the NCAM pathway suggests alternative mecha-
nisms by which GDNF proteins may contribute to impor-NCAM is a prominent cell adhesion molecule in the
nervous system, where it has been shown to participate tant biological processes in the developing and adult
nervous system.in a number of developmental processes including cell
migration, neurite outgrowth, and synaptic plastic-
ity (Crossin and Krushel, 2000; Ronn et al., 2000; Results
Schachner, 1997). The ability of NCAM to influence de-
velopmental events can result both from its adhesive Proximal Events in RET-Independent
as well as its signaling properties (Maness et al., 1996; GDNF Signaling
Saffell et al., 1995). The cytoplasmic domain of the GDNF signaling mechanisms were investigated in a line
of immortalized neuronal precursors (RN33B) and in pri-
mary cultures of Schwann cells. Both cell types have*Correspondence: carlos.ibanez@neuro.ki.se
1These authors contributed equally to this work. been reported to express relatively high levels of GFR1,
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Figure 1. GDNF Interacts Directly with NCAM
in Neuronal and Glial Cells
(A) Affinity labeling of RN33B cells with 125I-
GDNF, followed by chemical crosslinking and
immunoprecipitation (IP) with the indicated
antibodies. The membrane shown in the mid-
dle panel was reprobed (IB) with L1 antibod-
ies. Cold GDNF was used at 100-fold excess.
(B) Affinity labeling of Schwann cells and em-
bryonic hippocampal and cortical neurons
with 125I-GDNF, followed by immunoprecipita-
tion with NCAMICD or RET antibodies. Com-
plexes containing p140NCAM and PSA-NCAM
are indicated.
but no RET receptors (Trupp et al., 1997; Trupp et al., by immunoprecipitation with antibodies directed
against the intracellular domain of NCAM (NCAMICD), in1999), an observation that we could confirm by RT-PCR
analysis (see Supplemental Figure S1A online at http:// agreement with p120NCAM being a GPI-anchored protein
lacking an intracellular domain. The p180NCAM isoformwww.cell .com/cgi/content/ful l/113/7/867/DC1).
GDNF induced a rapid and transient stimulation of Fyn was not expressed by RN33B cells (data not shown).
GDNF did not bind to the related cell adhesion moleculetyrosine kinase activity in both cell types and a parallel
increase in phosphorylation of FAK on Tyr-397, a residue L1 (Figure 1A). Binding of 125I-GDNF to p140NCAM could
be displaced with excess cold GDNF, and was greatlyknown to be involved in the activation of this kinase
(Supplemental Figure S1B). GDNF treatment also stimu- attenuated following treatment with phosphatidylinosi-
tol phospholipase C (PI-PLC), which removes GPI-linkedlated protein tyrosine phosphatase activity in lipid rafts
of RN33B and Schwann cells (Supplemental Figure proteins from the cell membrane (Figure 1A). A complex
between p140NCAM and 125I-GDNF could also be identifiedS1C). These proximal signaling events correlated with
phosphorylation of the Erk1 and Erk2 MAP kinases (Sup- in Schwann cells and in embryonic hippocampal and
cortical neurons, which express high levels of NCAMplemental Figure S1D). Thus, proximal events in RET-
independent GDNF signaling in RN33B and Schwann and GFR1 but undetectable levels of RET (Trupp et al.,
1997; Yu et al., 1998) (Figure 1B). An additional highercells resemble the intracellular pathways activated by
p140NCAM, both in its time course and in the types of molecular weight complex was also observed in neu-
ronal cells representing GDNF binding to polysialic acidmolecules involved.
(PSA)-modified NCAM isoforms, which are highly ex-
pressed in embryonic neurons (Figure 1B). Immunopre-GDNF Binding to NCAM Activates Fyn Kinase
Affinity labeling experiments by chemical crosslinking cipitation with antibodies against RET did not bring
down any affinity-labeled complex from these cells (Fig-of 125I-GDNF to RN33B cells revealed, in addition to the
expected GDNF/GFR1 complex, two major receptor ure 1B). Together, these results indicated that GDNF is
able to interact directly and specifically with NCAM incomplexes of higher molecular weight corresponding
to the binding of GDNF to receptors of about 120 and RN33B cells, Schwann cells, and primary neurons.
Next, we investigated NCAM-associated signaling140 kDa, respectively (Figure 1A). Immunoprecipitation
of total cell lysates of affinity-labeled RN33B cells with events induced by GDNF. GFR1 has previously been
localized to lipid raft microdomains in the cell membraneantibodies directed against the extracellular domain of
NCAM (NCAMECD) recovered the two high molecular (Tansey et al., 2000; Paratcha et al., 2001). By virtue of
its cytoplasmic fatty acid acylation, a fraction of p140NCAMweight complexes (Figure 1A), suggesting that they rep-
resented GDNF binding to the p120NCAM and p140NCAM molecules have also been localized to these membrane
microdomains (Niethammer et al., 2002). First, we exam-isoforms. Only the largest complex could be recovered
NCAM Is a Signaling Receptor for GDNF
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Figure 2. GDNF Stimulates NCAM-Associated Fyn Kinase Activity in Neuronal and Glial Cells
(A) In vitro kinase assays on NCAM immunoprecipitates after GDNF stimulation of RN33B and Schwann cells. Purified lipid rafts were used
for RN33B cells. Phosphorylated products, including endogenous substrates (solid arrows) and exogenously added enolase (open arrows),
are indicated. Reprobings with NCAMICD antibodies are shown below each panel.
(B) Following NCAM immunoprecipitation and in vitro kinase assay, samples were eluted and reimmunoprecipitated with Fyn antibodies.
Phosphorylated Fyn is indicated (arrows). Supernatants were reimmunoprecipitated with NCAMICD antibodies followed by NCAMICD immunoblot-
ting (bottom).
(C) Activation of NCAM-associated Fyn in cortical neurons. In vitro kinase assay was performed on NCAM immunoprecipitates from cortical
neurons treated with GDNF (100 ng/ml) and then reimmunoprecipitated with Fyn antibodies. NCAMICD reprobing shown below.
(D) Activation of Fyn (left) and phosphorylation of Erk (right) in cortical neurons from wild-type and Ret knockout mice stimulated for 10 min
with GDNF (100 ng/ml). Immunoprecipitation of Fyn was followed by in vitro kinase assay and autoradiography. Fyn reprobing is shown below.
Erk phosphorylation was detected with anti-phospho-Erk antibodies (P-Erk) and controlled by reprobing with anti-AKT antibodies.
ined whether GDNF was able to stimulate NCAM-associ- stream signaling events in embryonic cortical neurons
isolated from wild-type and Ret knockout mice. GDNFated kinase activity by immunopurification of complexes
containing p140NCAM from lipid rafts or detergent-insolu- treatment stimulated Fyn autokinase activity in wild-type
as well as Ret knockout neurons (Figure 2D). GDNF alsoble membrane compartments followed by in vitro kinase
assay. In both RN33B and Schwann cells, GDNF treat- stimulated Erk phosphorylation to the same extent in
both types of neurons (Figure 2D), indicating that thesement caused rapid stimulation of NCAM-associated ki-
nase activity with a peak between 10 and 15 min (Figure signaling effects of GDNF were not mediated by the RET
receptor.2A). Several endogenous substrates that coimmuno-
precipitated with p140NCAM were phosphorylated follow-
ing GDNF stimulation (solid arrows), as well as enolase, High-Affinity GDNF Binding to NCAM
and Downstream Signaling Requiresthe exogenous substrate added to the reaction (open
arrows). To determine whether GDNF treatment stimu- Coexpression of GFRı Receptors
We then examined whether NCAM expression was suffi-lated the phosphorylation of the subpool of Fyn kinase
associated with p140NCAM, we performed an experiment cient to confer GDNF binding and signaling responses
to cells lacking endogenous GDNF receptors. COS cellssimilar to the one above except that after the in vitro
kinase reaction, proteins in NCAM-immunocomplexes do not express NCAM (Figure 3A) and are unable to
bind GDNF. However, following transfection of a cDNAwere solubilized in SDS and subjected to a second im-
munoprecipitation with anti-Fyn antibodies. In these encoding p140NCAM, we could detect binding of 125I-GDNF
to this NCAM isoform in COS cells (Figure 3A). Radiola-conditions, we could detect a robust induction in the
phosphorylation of NCAM-associated Fyn following beled brain-derived neurotrophic factor (BDNF) was un-
able to bind NCAM (Figure 3A). Cotransfection of theGDNF treatment in both RN33B and Schwann cells (Fig-
ure 2B). GDNF also stimulated a rapid and robust in- GFR1 coreceptor greatly potentiated binding of GDNF
to p140NCAM (Figure 3A). GFR2, another member of thecrease in Fyn phosphorylation in NCAM immunoprecipi-
tates of cortical neurons (Figure 2C), a signaling event GFR family that binds GDNF with lower affinity (Klein et
al., 1997), was not able to potentiate GDNF binding tothat resembles p140NCAM activation by homophilic bind-
ing (Beggs et al., 1997). We also investigated down- NCAM (Figure 3A). However, this receptor was able to
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Figure 3. Reconstitution of High-Affinity GDNF Binding to NCAM and Activation of Fyn in Heterologous Cells Requires Coexpression of GFR1
Receptors
(A) Affinity labeling of COS cells transfected with p140NCAM and different GFR receptors. All panels show NCAM immunoprecipitates from
cell lysates after chemical crosslinking with indicated ligands. NCAMICD reprobing is shown below.
(B) Displacement of 125I-GDNF binding to p140NCAM by soluble NCAMECD (used at 100- and 200-fold molar excess). Conditioned medium from
naive 293 cells was used as control.
(C) Saturation (top) and Scatchard (bottom) plots of 125I-GDNF binding to p140NCAM in the presence or absence of GFR1 in transfected COS
cells. Binding is expressed in arbitrary phosphorimager units (p units) obtained after phosphorimaging scanning of 125I-GDNF-labeled p140NCAM
complexes.
(D) Activation of Fyn in COS cells transfected with Fyn, p140NCAM, and GFR1 after GDNF stimulation (100 ng/ml). Immunoprecipitation of Fyn
(top) was followed by in vitro kinase assay and autoradiography. Fyn reprobing is shown below. The average increase at 15 min in four
independent experiments was 1.9-fold  0.2. Lower panels show double immunoprecipitation/in vitro kinase assays and reprobings with
NCAM and Fyn antibodies.
potentiate the binding of NTN, its high-affinity ligand, to cation of Fyn from solubilized in vitro kinase reactions
performed on NCAM immunocomplexes showed a ro-p140NCAM (Figure 3A). Moreover, GFR4 also potentiated
the binding of its cognate ligand PSP to COS cells that bust stimulation of the phosphorylation of NCAM-asso-
ciated Fyn kinase following GDNF treatment of COSalso received the cDNA encoding p140NCAM (Figure 3A).
Thus, NCAM is able to interact with several members of cells transfected with p140NCAM and GFR1 (Figure 3D).
The much greater increase in Fyn phosphorylation ob-the GDNF ligand family, but not with other neurotrophic
factors, and these interactions are greatly potentiated by served after a prior NCAM immunoprecipitation step
indicated that the subpopulation of Fyn molecules asso-coexpression of cognate members of the GFR family of
GPI-anchored coreceptors. Binding of GDNF to NCAM ciated with p140NCAM is preferentially responsive to GDNF
stimulation. Together, these data indicated that NCAMcould be displaced by soluble NCAMECD (Figure 3B), fur-
ther attesting to the specificity of their interaction. is sufficient to confer GDNF binding to heterologous
cells, but that high-affinity binding and ligand-depen-Equilibrium binding, analyzed by chemical crosslink-
ing and SDS-PAGE, indicated that binding of GDNF to dent activation of NCAM-associated Fyn kinase requires
coexpression of cognate members of the GFR familyNCAM was saturable in the low nM range (Figure 3C).
Coexpression of GFR1, increased both the binding af- of GPI-linked receptors.
finity of GDNF for NCAM (KdNCAM  5.2  1.8 nM versus
KdNCAMGFR1 1.1 0.32 nM; n 3) as well as the GDNF Complex Formation between GFR1 and NCAM
Downregulates Homophilic NCAM Interactionsbinding Bmax of NCAM molecules (BmaxNCAMGFR1/
BmaxNCAM  3.7) without altering total NCAM levels in and NCAM-Mediated Cell Adhesion
The effects of GFR1 on the ability of NCAM to bindtransfected cells. GDNF treatment of COS cells cotrans-
fected with GFR1 and p140NCAM stimulated Fyn kinase GDNF suggested that GFR1 may interact directly or
indirectly with NCAM. To investigate this possibility, weactivity as assessed by in vitro autokinase assay in Fyn
immunoprecipitates from transfected cells (Figure 3D). performed a coimmunoprecipitation assay in COS cells
transfected with p140NCAM together with increasingGDNF was unable to stimulate Fyn kinase activity in
cells that received either NCAM or GFR1 alone (Figure amounts of GFR1. Cell surface molecules were labeled
by whole-cell biotinylation prior to immunoprecipitation3D), indicating the necessity of both receptor compo-
nents for efficient intracellular signaling. Immunopurifi- with NCAMICD antibodies. High levels of cell surface
NCAM Is a Signaling Receptor for GDNF
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Figure 4. Complex Formation between GFR1 and NCAM Inhibits Homophilic NCAM Interactions and NCAM-Mediated Cell Adhesion
(A) Coimmunoprecipitation of hemagglutinin (HA)-tagged GFR1 and NCAM in the surface of transfected COS cells. Biotinylated NCAM and
GFR1 were detected by NCAM immunoprecipitation and probing with neutravidin. Reprobings with anti-HA and NCAM antibodies are shown.
(B) Direct physical interaction between p140NCAM and GFR1 in transfected COS cells analyzed by chemical crosslinking and immunoprecipita-
tion. Monomeric p140NCAM (arrowhead), oligomeric NCAM complexes (solid arrows), and complexes containing both NCAM and GFR1 (open
arrows) are indicated.
(C) Chemical crosslinking of radiolabeled PSA-NCAM to COS cells expressing HA-tagged p140NCAM in the presence or absence of different
amounts of transfected GFR1 (in g plasmid DNA). Reprobing with anti-HA antibodies is shown below.
(D) Cell adhesion assay in Jurkat cells transiently transfected with p140NCAM and increasing amounts of GFR1 (in g plasmid DNA). Only cell
aggregates containing more than five cells were counted (arrows). Results are expressed as number of aggregates per 1000 GFP-positive
cells  SD (n  4). Similar results were obtained in three independent experiments. Scale bar, 50 m.
(E) Chemical crosslinking of 125I-GDNF to COS cells transfected with p140NCAM and increasing amounts of GFR1 (in g plasmid DNA).
Quantitative results are expressed as 125I-GDNF binding  SD (n  3) relative to p140NCAM alone and normalized to the levels of p140NCAM in
each lane as determined by immunoblotting.
p140NCAM and GFR1 could be detected in NCAM immu- sult indicated that the association between NCAM and
GFR1 is direct and suggested that this interaction maynoprecipitates (Figure 4A), indicating that the two recep-
tors associate in the same molecular complex at the cell be accompanied by alterations in the ability of NCAM
to interact with other NCAM molecules. We thereforesurface. No GFR1 could be recovered in the absence of
NCAM (Figure 4A). Coimmunoprecipitation of GFR1 assayed homophilic NCAM binding by chemical cross-
linking of a radiolabeled preparation of purified PSA-with endogenous NCAM could also be detected in
RN33B cells (data not shown). In cells expressing en- NCAM to cells transfected with p140NCAM in the presence
or absence of GFR1. Following immunoprecipitationdogenous NCAM, overexpression of GFR1 resulted in
an increase in the level of p140NCAM localized to lipid rafts of epitope-tagged p140NCAM, a broad band of high molec-
ular weight (300 kDa) corresponding to NCAM-NCAM(see Supplemental Figure S2 online at http://www.cell.
com/cgi/content/full/113/7/867/DC1), suggesting stabi- complexes could be detected in cells expressing
p140NCAM (Figure 4C). Interestingly, coexpression oflization or recruitment of p140NCAM in this compartment
by interaction with GFR1. GFR1 reduced the formation of this complex in a dose-
dependent manner without affecting the total levels ofChemical crosslinking of monolayers of cells trans-
fected with p140NCAM allowed the detection of a high p140NCAM expressed in the cells (Figure 4C), indicating
that the interaction between GFR1 and NCAM down-molecular weight complex ( 300 kDa), likely represent-
ing oligomerization of NCAM molecules (Figure 4B, solid regulates NCAM homophilic binding.
The effects of GFR1 expression on NCAM functionarrow). Cotransfection with GFR1 inhibited the forma-
tion of this complex and resulted in the appearance were further tested in a cell adhesion assay performed
in transiently transfected Jurkat cells. Control Jurkatof a lower molecular weight complex containing both
p140NCAM and GFR1 (Figure 4B, open arrows). This re- cells expressing green fluorescence protein (GFP) grew
Cell
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as a suspension of dispersed individual cells (Figure NCAMECD treatments affected cell viability or the motility
of Schwann cells grown on control fibroblasts (data not4D). Upon transfection with p140NCAM, GFP-expressing
Jurkat cells formed cell aggregates of variable sizes, shown). A comparable effect of GDNF on Schwann cell
motility could be observed in sciatic nerve explants iso-including 2 to about 20 cells, indicating NCAM-mediated
cell adhesion (Figure 4D). Coexpression of GFR1 re- lated from Ret knockout mice (Figure 5B), indicating that
this activity was not mediated by the RET receptor. Induced the formation of cell aggregates mediated by
NCAM in a dose-dependent manner (Figure 4D), without contrast, GDNF-mediated Schwann cell migration was
abolished in explants isolated from Ncam mutant micealtering the intensity or the number of GFP-positive cells
or the levels of p140NCAM at the cell surface (see Supple- (Figure 5C), supporting the participation of NCAM in this
biological activity.mental Figure S3 online at http://www.cell.com/cgi/
content/full/113/7/867/DC1). Even low relative levels of
GFR1 had a significant effect on NCAM-mediated cell GDNF Stimulates Axonal Growth in Primary
adhesion. Addition of GDNF had no detectable effect Neurons via NCAM and Fyn Kinase
on the adhesion of NCAM-expressing cells (see Supple- but Independently of RET
mental Figures S4A and S4B online at http://www.cell. Previous work had shown that hippocampal neurons
com/cgi/content/full/113/7/867/DC1). On the other hand, plated on a monolayer of fibroblasts expressing NCAM
a soluble GFR1-Fc fusion protein reduced the forma- on their surface develop longer neuritic extensions than
tion of cell aggregates in NCAM-transfected cells in a control cultures grown on naive cells (Doherty and
dose-dependent manner (Supplemental Figure S4A). At Walsh, 1994). We therefore investigated whether GDNF,
the same ratios of coexpression, a reciprocal increase via its interaction with NCAM and activation of NCAM-
in GDNF binding to p140NCAM was observed in COS cells associated pathways, could stimulate neurite outgrowth
cotransfected with increasing doses of GFR1 (Figure in primary hippocampal and cortical neurons isolated
4E). Together, these data indicated that GFR1 can form from the embryonic rat brain. We examined the length
a complex with NCAM at the cell surface, resulting in of the longest neurite in neuronal cultures plated on
increased GDNF binding and decreased homophilic in- different substrates, including plain tissue-culture plas-
teractions between NCAM molecules. tic, bovine serum albumin (BSA), cytochrome C (cyto-C),
poly-D-lysine (PDL), IgG, and GDNF. Although neurons
plated on PDL developed many more processes thanGDNF Stimulates Schwann Cell Migration
via NCAM but Independently of RET those plated on plastic or on any of the control proteins,
the length of the longest neurite was not significantlyTo address the physiological significance of the role of
NCAM as an alternative signaling receptor for GDNF, different between PDL and control treatments, reaching
on average 150–200 m after 2 days in culture (Figurewe examined biological responses in primary glial cells
and neurons predominantly expressing GFR1 and 6A). However, hippocampal and cortical neurons plated
on GDNF developed neurites that were at least twiceNCAM but little or no RET. Previous work had implicated
NCAM in cell migration, and a recent study demon- as long, reaching on average 400 m (Figure 6A). The
combination PDLGDNF was also able to promote axo-strated a specific role of NCAM in the migration of
Schwann cells from peripheral nerve explants (Thomai- nal growth beyond the effect of PDL alone (data not
shown). Denatured GDNF had no effect on neurite out-dou et al., 2001). GDNF is highly expressed in developing
and regenerating peripheral nerves, suggesting a role growth (Figure 6A), indicating the requirement of a native
three-dimensional conformation. A significant increasefor GDNF in the control of Schwann cell migration. To
investigate whether GDNF was able to stimulate in neurite length could also be observed in hippocampal
and cortical neurons growing on a monolayer of fibro-Schwann cell migration via the NCAM pathway, explants
of newborn rat sciatic nerve were cultured on confluent blasts expressing GDNF compared to control fibroblasts
(see Supplemental Figure S5A online at http://www.cell.cell monolayers of Fisher rat 3T3 (FR3T3) fibroblasts
genetically engineered to stably express GDNF (Arenas com/cgi/content/full/113/7/867/DC1). Neurons plated
on PDL presented a greater number of primary neuriteset al., 1995). Control cultures were established on mono-
layers of naive FR3T3 fibroblasts. After 3 days in culture, than those plated on GDNF, which instead displayed
one major long process (Figure 6A), suggesting thatexplants grown on fibroblasts expressing GDNF dis-
played a large halo of exiting Schwann cells (Figure 5A). GDNF primarily stimulated axonal growth in these cells.
Interestingly, this response was qualitatively differentMany more cells were observed leaving the explants
stimulated with GDNF than those grown on control fibro- from that elicited by BDNF, an established and potent
neurotrophic factor for these neuronal subpopulations,blasts (Figure 5A). Independent experiments demon-
strated that GDNF does not promote Schwann cell pro- which was characterized by a greater number of shorter
primary neurites and a more profuse neuritic branchingliferation (data not shown), indicating that GDNF
stimulates robust Schwann cell migration from sciatic (Supplemental Figure S5B).
The effects of GDNF on axonal growth could be elimi-nerve explants. The distance covered by the leading
migrating Schwann cell was on average 60% longer in nated by treatment with PP2 but were not affected by
the FGFR kinase inhibitor SU5402 (Figure 6A). PP2 hadexplants cultured on GDNF-expressing fibroblasts than
in controls (Figure 5A). The effects of GDNF could be no effect on the viability of the cells. Importantly, GDNF-
mediated outgrowth could be reduced using anti-suppressed by low doses of the Fyn kinase inhibitor
PP2 (1 M) or by anti-NCAMECD and anti-GDNF blocking NCAMECD function-blocking antibodies (Figure 6B), indi-
cating the involvement of NCAM in this activity. Theantibodies (Figure 5A). Control antibodies had no effect
on Schwann cell migration, and neither PP2 or anti- effect of GDNF could also be partially attenuated by
NCAM Is a Signaling Receptor for GDNF
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Figure 5. GDNF Promotes Schwann Cell Mi-
gration via NCAM but Independently of RET
(A) Migration of Schwann cells (S-100 stain-
ing) from newborn rat sciatic nerve explants
plated on naive (control) or GDNF-expressing
FR3T3 fibroblasts (GDNF). Scale bar, 200m.
The results correspond to the averages 
SEM of the means of four independent exper-
iments, each including measurements from 5
to 12 different explants. *p  0.001.
(B) Migration of Schwann cells from newborn
mouse sciatic nerve explants isolated from
Ret knockout mice. Shown is the mean of at
least four different explants  SD from three
animals in each condition. *p  0.001.
(C) Migration of Schwann cells from newborn
mouse sciatic nerve explants isolated from
Ncam knockout mice. Shown is the mean of
at least five different explants  SD from
three animals in each condition.
function-blocking antibodies against GFR1 (Supple- is caused by defects in the migration of neuronal precur-
sors in the rostral migratory stream (RMS), a migratorymental Figure S5C). Antibodies against the NCAM intra-
cellular domain (Figure 6B) or RET (Supplemental Figure pathway that delivers cells from the subventricular zone
to the olfactory bulb during postnatal and adult life (Gar-S5C) had no effect. Neither PP2 or anti-NCAMECD treat-
ments had any significant effect on the neurite out- cia-Verdugo et al., 1998). NCAM is essential for correct
chain migration of neuronal precursors in the RMS, agrowth of cells plated on PDL (Figures 6A and 6B). GDNF
was able to stimulate neurite outgrowth in embryonic process whereby cells use each other as the migratory
hippocampal neurons isolated from Ret knockout mice substrate (Lois et al., 1996). In the absence of NCAM,
to a similar extent than in wild-type neurons (Figure 6C), neuronal progenitors accumulate along the RMS, pro-
confirming that this activity was mediated independently ducing characteristic enlargements over the entire
of the RET receptor. In contrast, GDNF-mediated neurite length of the pathway, particularly in its most caudal
outgrowth in embryonic cortical and hippocampal neu- portion between the corpus callosum and the striatum
rons isolated from Ncam knockout mice was severely (Chazal et al., 2000). The ability of GFR1 to modulate
reduced compared to wild-type (Figure 6D), providing NCAM-mediated cell adhesion and migration prompted
genetic evidence for the participation of NCAM in the us to investigate the expression of GFR1 in the RMS.
biological response of these cells to GDNF. Of note, lack Analysis of sagittal sections of adult brain by immunoflu-
of NCAM did not affect the response of hippocampal orescence revealed a striking juxtaposition of GFR1
neurons to BDNF (Figure 6E). Together, these results and PSA-NCAM expression along the entire RMS (Figure
demonstrated a neurite outgrowth-promoting activity of 7A). RET immunoreactivity could not be detected in the
GDNF on hippocampal and cortical neurons that was pathway (Figure 7A), although cells in the facial motor
dependent on NCAM expression and function and on nucleus were readily labeled (Figure 7A, inset). As ex-
the activity of Fyn kinase but that was independent of pected, no signal for PSA-NCAM could be detected in
signaling by the RET receptor tyrosine kinase. sections from adult Ncam mutant mice (Figure 7A). On
the other hand, staining for GFR1 revealed the charac-
teristic enlargement of the mutant RMS at its exit in theGFR1 and NCAM in the Development
anterior horn of the lateral ventricle and in its ventralof the Rostral Migratory Stream
projection (Figure 7A), indicating that cells affected inIn this last section, we turn our attention to some of the
the RMS of Ncam mutant mice express GFR1.possible implications of the interactions between GDNF,
The premature death of mice lacking GFR1 duringGFR1, and NCAM for development in vivo. The most
the first hours after birth prevented us from studyingdistinctive abnormality of the central nervous system of
the adult RMS in these animals. We therefore examinedmice lacking NCAM is a dramatic reduction of the size
of the adult olfactory bulbs (Cremer et al., 1994). This PSA-NCAM and GFR1 expression in wild-type and mu-
Cell
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Figure 6. GDNF Promotes Axonal Growth in Hippocampal and Cortical Neurons via Fyn and NCAM but Independently of RET
(A) Representative photomicrographs of embryonic rat hippocampal and cortical neurons grown on PDL or GDNF (	 III tubulin staining). Scale
bar, 50 m. Results are mean  SEM from a representative experiment performed in triplicate. *p 
 0.001 versus PDL or GDNFPP2 (ANOVA).
Similar results were obtained in four independent experiments.
(B) Blockade of GDNF outgrowth activity by NCAMECD antibodies. Scale bar, 50 m. *p  0.001 (ANOVA). Four independent experiments were
performed with similar results.
(C) Axonal outgrowth in hippocampal neurons from wild-type and Ret knockout mice. Scale bar, 25 m. Similar results were obtained in three
independent experiments.
(D) Axonal outgrowth in cortical and hippocampal neurons from wild-type and Ncam knockout mice. *p 
 0.01, compared to wild-type
(Student’s t test). Similar results were obtained in three independent experiments.
(E) Neurite outgrowth of hippocampal neurons from Ncam heterozygous and knockout mice grown on BDNF. The length of the complete
dendritic arbor was measured in these experiments.
tant newborn mice. As previously reported, staining for born mice lacking GFR1. To this end, we measured
the width of the caudal portion of the RMS after thisPSA-NCAM in the newborn mouse brain was broadly
distributed and included the developing RMS, which at turns ventrally from the lateral ventricle in equivalent
sagittal sections of wild-type and Gfra1 mutant brainsthese early stages comprises a broad band of migrating
cells (Figure 7B). At this stage, GFR1 expression was stained with anti-PSA-NCAM antibodies. This analysis
revealed a statistically significant increase in RMS widthmore restricted than that of PSA-NCAM and localized
prominently in the developing RMS, the subventricular in the brain of newborn mice lacking GFR1 (Figure 7D).
No such difference could be observed in the RMS ofzone and the olfactory bulb (Figure 7B). Many cells in
the middle portion of the RMS appeared to coexpress Ret mutant animals (Figure 7D), suggesting a RET-inde-
pendent role for GFR1 in RMS development.PSA-NCAM and GFR1 at this stage (Figure 7C). As
expected, no staining for GFR1 was observed in the
brain of newborn Gfra1 mutants (Figure 7B), confirming Discussion
the specificity of the patterns observed in wild-type ani-
mals. Staining for PSA-NCAM revealed essentially the The presence of GFR receptors in many regions of the
central and peripheral nervous systems in the absencesame pattern as in newborn wild-type animals; no signif-
icant difference in the overall size of the olfactory bulb of RET has suggested the existence of alternative, RET-
independent signaling mechanisms for GDNF family li-of Gfra1 mutants could be recognized at this early stage
of development (Figure 7B). We examined whether early gands, presumably mediated by the collaboration of
GFRs with unknown transmembrane receptors (Truppsigns of RMS enlargement could be discerned in new-
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Figure 7. GFR1 and NCAM in the Develop-
ment of the Rostral Migratory Stream
(A) Expression of PSA-NCAM and GFR1 in
sagittal sections of the RMS of adult mice.
The inset shows prominent RET staining in
cells of the adult facial motor nucleus. Arrow-
heads delineate the RMS stained with GFR1
antibodies. Abbreviations: cc, corpus callo-
sum; rms, rostral migratory stream; st, stria-
tum; v, ventricle. Scale bars, 100 m.
(B and C) Expression of PSA-NCAM and
GFR1 in the RMS of newborn mice. Arrows
indicate the developing RMS. Boxed areas
are shown at higher magnification in (C).
Scale bar, 200 m.
(D) Morphometric analysis of the RMS in new-
born wild-type, Gfra1, and Ret mutant mice.
The region measured in equivalent sections
of wild-type and mutant animals is indicated
in diagram form. The scatter graphs show
measurements of RMS width for each individ-
ual animal normalized to the mean value in
wild-type mice. Bars indicate the mean value
in each group. *p  0.0136, Student’s t test.
et al., 1997, 1999). Here, we have shown that the neural here are physiologically relevant for these cells. Our
results demonstrate that NCAM and GFR1 associate incell adhesion molecule NCAM, in collaboration with
GFR receptors, can function as a signaling receptor the same molecular complex and reveal an unexpected
ability of GFR1 to gate NCAM function. The dose-depen-for members of the GDNF ligand family independently
of the presence of RET, thereby providing an explana- dent, reciprocal effects of GFR1 on NCAM-mediated
cell adhesion and GDNF binding suggest that interac-tion for the tissue distribution of GFR proteins. NCAM
is abundantly expressed in cell types that also express tions between GFR1 and NCAM molecules may result
in conformational changes in NCAM that favor GDNFhigh levels of GFR molecules, but not RET, including
Schwann cells and hippocampal and cortical neurons binding over homophilic interactions, thereby regulating
the ability of NCAM to interact with different ligands.(Crossin and Krushel, 2000). In vivo, all these cell types
are normally exposed to GDNF in a paracrine or auto- Our findings suggest that a number of functions pre-
viously ascribed to short-range signaling by homophiliccrine fashion (Trupp et al., 1997), suggesting that the
signaling pathways and biological effects described interactions between NCAM molecules, including regu-
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lation of axonal growth, cell migration, and synaptic tial learning similar to those observed in Ncam mutants
plasticity, could also be mediated by the interaction of (Gerlai et al., 2001). In addition, a recent study reported
long-range signaling messengers, such as GDNF family that effects of GDNF on survival, growth, and function of
ligands, with NCAM receptors. Schwann cell migration midbrain dopaminergic neurons could be antagonized
is an important developmental process for the formation with anti-NCAM function blocking antibodies both in
of peripheral nerves and plays a critical role during nerve vitro and in vivo (Chao et al., 2003), an observation that
regeneration. Schwann cells express high levels of supports the physiological relevance of GDNF/NCAM
NCAM, GFR1, and GDNF, all of which become upregu- interactions in this system.
lated following nerve injury and Schwann cell activation. The ability of GFR1 to modulate NCAM-mediated
Mechanisms controlling the balance between adhesion cell adhesion, even in the absence of GDNF, together
and motility are likely to be of importance for the regula- with its prominent localization in the developing and
tion of cell migration. Thus, through their ability to regu- adult RMS, suggests that GFR1/NCAM interactions
late both NCAM-mediated cell adhesion and motility, may play a role in the migration of neuronal progenitors
GDNF and GFR1 may also contribute to the control of along this pathway and in the development of the olfac-
Schwann cell migration during peripheral nerve develop- tory bulb. In agreement with this notion, the developing
ment and regeneration. RMS of newborn Gfra1 mutants appeared moderately
Our results also indicate that GDNF can utilize NCAM enlarged, a phenotype that was absent in newborn Ret
signaling pathways to promote axonal growth in hippo- mutants but that resembled the enlargement of the RMS
campal and cortical neurons. The lack of involvement that is characteristic in adult mice lacking NCAM (Chazal
of the FGFR in GDNF-mediated outgrowth is a notable et al., 2000). In future studies aimed to address the role
difference with NCAM activation by homophilic binding of GDNF/ and GFR1/NCAM interactions in vivo, it will
(Doherty and Walsh, 1996). The possibility that GDNF be necessary to employ strategies designed to disrupt
family ligands may participate in the regulation of synap- GDNF and GFR1 function specifically in postnatal and
tic plasticity is particularly interesting in view of the adult stages and to dissect the specific contributions
marked impairments in spatial learning and induction of RET and NCAM to the observed phenotypes.
of long-term potentiation (LTP) observed after loss of In conclusion, our findings indicate that crosstalk be-
NCAM function (Cremer et al., 2000, 1994; Doherty et tween different systems of cell communication may be
al., 1995; Luthl et al., 1994). Intriguingly, seizure activity more prevalent than previously thought. Crosstalk be-
is known to regulate the expression of GDNF family tween extracellular components could reflect a level of
ligands and GFR receptors in limbic structures (Kokaia signal integration required for the coordination of multi-
et al., 1999), and development of hippocampal kindling cellular responses. The interactions we describe here
epilepsy, a form of synaptic plasticity, is markedly re- between NCAM and GDNF family ligands and GFR
duced in mice lacking GFR2 (Nanobashvili et al., 2000). receptors reveal NCAM as a surprisingly versatile trans-
Our results suggest that GDNF family ligands may con- membrane receptor capable of mediating both short-
tribute to the regulation of synaptic plasticity in the brain and long-range intercellular communication via distinct
via activation of NCAM signaling pathways. ligand systems.
Despite NCAM’s broad expression and widely docu-
mented roles in adhesion, migration, and growth, mice Experimental Procedures
lacking NCAM are viable and fertile (Cremer et al., 1994).
Recombinant Proteins, Cell Lines, and MiceMoreover, all phenotypes so far reported in these ani-
GDNF, GFR1-Fc, and ALK4-Fc were purchased from R&D, NTNmals, which include deficits in neuronal migration, syn-
was purchased from Peprotech, and recombinant Persephin (PSP)
aptic organization, plasticity, and spatial learning, do was a gift from Miroslav Cik and Bob Gordon, Jannssen Research
not appear until later in postnatal and adult life (Chazal Foundation (Belgium). Purified PSA-NCAM was obtained from
et al., 2000; Cremer et al., 1994; Esni et al., 1999; Holst Chemicon (cat. no. AG265). RN33B is an immortalized neuronal
precursor cell line isolated from embryonic raphe nucleus (Trupp etet al., 1998; Muller et al., 1996; Polo-Parada et al., 2001;
al., 1999). Fisher rat 3T3 fibroblasts producing GDNF have beenStork et al., 1997; Tomasiewicz et al., 1993). On the other
described previously (Arenas et al., 1995). Ret knockout mice (Schu-hand, the analysis of mice lacking GDNF has so far been
chardt et al., 1994) were provided by Judith Crusells and Martfocused on two main phenotypes, i.e., renal agenesis
Saarma with the kind permission of Vassilis Pachnis. Ncam knockout
and absence of enteric neurons (Moore et al., 1996; mice (Cremer et al., 1994) were obtained from the Jackson Labora-
Pichel et al., 1996; Sa´nchez et al., 1996), which appear tory (Maine). Gfra1 mutant mice (Cacalano et al., 1998) were kindly
early during embryonic development and lead to the provided by Arnon Rosenthal.
premature death of these animals a few hours after birth.
RET and GFR1 RT-PCRBoth these phenotypes are also found in mice lacking
Total RNA was isolated from RN33, Schwann cells, or adult ratRET (Schuchardt et al., 1994) and are therefore likely
cerebellum using SNAP columns (Invitrogen) according to the manu-
mediated by this receptor. It is at present unclear to facturer’s instructions. Single-stranded cDNA was synthesized us-
which extent lack of GDNF, or RET, affects the develop- ing Multiscribe Reverse Transcriptase and random hexamers (Per-
ment of the central nervous system, and direct compari- kin-Elmer). The cDNA was amplified using the following specific
primers: rat RET forward primer, 5-CCCGTGTGTACTTCTCCTTsons between the two mutants are yet to be performed.
CAT-3; reverse primer, 5-GCACTCAGCCTCCAGCAC-3; rat GFR1In addition, the early lethality of these animals has pre-
forward primer, 5-GCGTGCACCGAGCGGCGCCGACAGACTATCG-3;cluded investigation of the roles of GDNF in brain matu-
reverse primer, 5-TTCCAGGTCATTTCCGGAGTTGCTGCAGTC-3.ration and function that can be anticipated from its pat-
tern of expression in the postnatal and adult nervous Cell Transfection and Plasmids
system. Intriguingly, heterozygote Gdnf knockout mice, Transient transfection of COS cells was performed using the calcium
phosphate method. Plasmid cDNA encoding p140NCAM (without VASEwhich survive to adulthood, present deficiencies in spa-
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sequence) was kindly provided by Patricia Maness. cDNAs for rat nonradioactive phosphatase assay system (Promega) based on the
substrate DADE(pY)LIPQQG according to the manufacturer’s in-GFR1 and GFR2 were described previously (Trupp et al., 1998).
Chicken GFR4 cDNA was a gift from Alun Davies. Human Fyn structions. Protein concentrations were evaluated by the micro-BCA
method (Pierce).cDNA was kindly provided by Tohru Tezuka. The GFP plasmid was
from Clontech.
Total Cell Lysates, Immunoprecipitation,
and Western BlottingCell Adhesion Assay
Jurkat cells were transfected in 24-well plates (1.3 g total DNA per For total cell lysates, cells were lysed for 60 min at 4C in buffer
containing 0.5% Triton X-100, 1% 	-octylglucoside plus proteasewell) using the Fugene-6 reagent (Roche) in 0.5 ml complete medium
with 10% serum. 2 days after transfection, they were transferred to and phosphatase inhibitors. Protein lysates were clarified and ana-
lyzed by immunoprecipitation and Western blotting as previously12-well plates and 0.5 ml serum-free medium was added. On the
third day, cell aggregates larger than five cells were counted in described (Paratcha et al., 2001). All blots were scanned in a Storm
840 fluorimager and quantifications were done with ImageQuanteach well under green fluorescence illumination. The total number
of green cells was also counted for normalization. NCAM immunoflu- software (Molecular Dynamics). The antibodies were obtained from
various sources as follows: anti-Fyn and anti-FAK from Upstateorescence was performed on cells fixed and permeabilized as indi-
cated below using anti-NCAMICD antibodies (Developmental Studies Biotechnology (Lake Placid, NY); anti-phospho-FAK (Tyr-397) from
Biosource (Camarillo, CA); anti-AKT and anti-Phospho-ERK (Thr-Hybridoma Bank).
202/Tyr-204) from New England Biolabs; monoclonal anti-HA from
Covance; anti-RET and anti L1 from Santa Cruz BiotechnologySchwann Cell Preparation and Migration Assays
(Santa Cruz, CA); monoclonal antibodies anti-NCAMICD (12F11) andSchwann cells were extracted from the newborn rat sciatic nerve
anti-NCAMECD (N-CAM13) from BD PharMingen. Whole-cell biotiny-by collagenase treatment and cultured serum-containing medium
lation was performed with the EZ-link reagent (Pierce), following thesupplemented with bFGF and forskolin. At confluence, cultures were
manufacturer’s instructions.switched to serum-free medium before stimulation with GDNF. For
Schwann cell migration studies, sciatic nerves were dissected out
from newborn rats or mice, subjected to collagenase treatment, In Vitro Kinase Assay
Fyn or NCAM immunoprecipitates were assayed by in vitro kinaseand placed onto confluent monolayers of either control or GDNF-
expressing FR3T3 fibroblasts in 24-well plates. Cultures were al- assay as previously described (Trupp et al., 1999). In some experi-
ments, the NCAM immunocomplexes were eluted by 10 min incubationlowed to grow in complete medium (5% serum) for an additional
2–3 days, after which they were permeabilized, fixed, and stained at 100C in 2% SDS, and supernatants were then diluted 20-fold in
lysis buffer and reimmunoprecipitated with anti-Fyn antibodies. Aswith antibodies against S-100 (rat) or p75 (mouse). In each explant,
Schwann cell migration was quantified as the distance from the loading control, the supernatant of the Fyn immunoprecipitation
was reprecipitated and immunoblotted with anti-NCAMICD anti-border of the explant to the leading migrating cell.
bodies.
Chemical Crosslinking and Binding Assays
Ligands were iodinated by the lactoperoxidase method and chemi- Neurite Outgrowth Assay and Pharmacological Treatments
Rat hippocampal and cortical cells from embryonic day (E)17.5 andcal crosslining was performed with ethyl-dimethyl-aminopropyl-car-
bodimide (EDAC) supplemented with sulfo-NHS (Pierce). Cells were mouse cortical cells from E15.5 embryos were cultured in Neuroba-
sal (Gibco) supplemented with B27 (Gibco). Mouse hippocampallysed in buffer containing 0.5% Triton X-100 and 60 mM 	-octyl-D-
glucopyranoside (Pierce) to ensure complete solubilization of mem- cells (E15.5) were cultured in N2 medium. Tissue culture dishes (48-
well) were coated with the indicated proteins at 10 g/ml followedbrane lipid rafts. For PI-PLC treatments, cell monolayers were
washed and then incubated with 1 U/ml PI-PLC (Sigma) in cell cul- by three washes with PBS. Three thousand cells were plated per
well and cultured for 48 hr. The cells were then fixed in 4% paraform-ture medium for 60 min at 37C followed by affinity labeling as above.
Soluble NCAM extracellular domain (NCAMECD) was produced in the aldehyde, permeabilized with 0.3% Triton X-100, and stained with
anti-	 III tubulin (Promega). For blocking experiments, PP2 (Alexis)supernatant of 293 cells stably transfected with a cDNA encoding
N terminally, hemagglutinin (HA)-tagged rat NCAMECD, concentrated was used at 1 M, SU5402 (Calbiochem) at 10 M, and the mono-
clonal anti-NCAMECD (MAB310, Chemicon) was utilized at 5 g/ml.by ultrafiltration and quantified by immunoblotting. Purified PSA-
NCAM was iodinated by the lactoperoxidase method. Following Function-blocking anti-GFR1 antibodies or anti-RET antibodies
(R&D Systems) were added at 12 g/ml. GDNF-expressing fibro-chemical crosslinking with 125I-PSA-NCAM (performed as above), an
acid wash was made to remove radiolabeled probe unspecifically blasts for coculture experiments were obtained by transient trans-
fection of MG87 cells (a derivative of NIH3T3 fibroblasts) as pre-adsorbed to the cells, followed by several washes with PBS and
cell lysis as above. viously described (Arenas et al., 1995). Quantification of neurite
length was done with the IP-Lab Spectrum software package. AtFor saturation binding assays, increasing concentrations of 125I-
GDNF were incubated with COS cells monolayers transfected with least 200 neurons were evaluated in each well; three wells were
counted per experiment; each experiment was repeated four times.p140NCAM alone or together with GFR1. Equilibrium was reached
after a 4 hr incubation at 4C in phosphate buffer saline (PBS) supple-
mented with Ca2 and BSA. This was followed by chemical crosslink- Immunofluorescence and Microscopy
ing, EDAC neutralization with 500 mM glycine, two washes in PBS, Cryostat sections (20 m) of adult newborn mouse brains were
and cell lysis as above. Cell lysates were immunoprecipitated with generated as previously described (Trupp et al., 1997, 1998). Sec-
anti-NCAMICD antibodies, separated by SDS-PAGE, and blotted onto tions were blocked with 5% donkey serum and incubated with pri-
PVDF membranes. After autoradiographic exposure to phosphor- mary antibodies: mouse monoclonal anti-PSA-NCAM (Chemicon),
screens, the band corresponding to the complex between 125I-GDNF affinity-purified rabbit polyclonal anti-GFR1 (provided by Michele
and p140NCAM was quantified using a Storm 840 phosphorimager Sanicola), and hamster monoclonal anti-RET (provided by David
and ImageQuant software (Molecular Dynamics). For each ligand Anderson). Secondary antibodies conjugated to fluorescein isothio-
concentration, the level of 125I-GDNF bound to p140NCAM was normal- cyanate (FITC) or rhodamine (TRITC) were from Jackson Immunore-
ized to the total levels of p140NCAM expressed (determined by NCAM search Lab. Confocal microscopy was performed in a Zeiss LSM
immunoblotting of the same membranes) and then plotted as a 510 confocal microscope. Morphometric analysis of the RMS in
function of the total amount of 125I-GDNF added. A linear transforma- newborn mice was performed on sagittal sections stained with PSA-
tion of these data was made in a Scatchard plot analysis. NCAM, where the RMS could be seen as a stream of cells extending
from the anterior limit of the lateral ventricle to the caudal boundary
of the olfactory bulb. We measured the width of the caudal portion ofLipid Rafts and PTP Activity
Preparation of rafts was performed as previously described (Parat- the RMS after it turns ventrally from the lateral ventricle in equivalent
sagittal sections of wild-type and mutant mice using the OpenLabcha et al., 2001). Protein tyrosine phosphatase activity was evalu-
ated in duplicates of lipid raft fractions (8–10 g of protein) using a software package.
Cell
878
Acknowledgments adhesion molecule and synaptic plasticity. J. Neurobiol. 26,
437–446.
We thank Michele Sanicola for generously providing GFR1 antibodies; Durbec, P., Marcos-Gutierrez, C.V., Kilkenny, C., Grigoriou, M., Su-
Svend Kjær for conditioned medium containing soluble NCAMECD; vanto, P., Wartiovaara, K., Smith, D., Ponder, B., Costantini, F.,
Patricia Maness and Tohru Tezuka for NCAM and Fyn plasmids; Saarma, M., et al. (1996). Glial cell line-derived neurotrophic factor
Vassilis Pachnis, Judith Crusells, and Mart Saarma for Ret knockout signalling through the Ret receptor tyrosine kinase. Nature 381,
mice; Arnon Rosenthal for Gfra1 knockout mice; Ernest Arenas for 789–792.
GDNF-expressing fibroblasts; Pablo Brumovsky and Helena Mira
Esni, F., Taljedal, I.B., Perl, A.K., Cremer, H., Christofori, G., andfor additional help; Mike Fainzilber and Wilma Friedman for com-
Semb, H. (1999). Neural cell adhesion molecule (N-CAM) is requiredments on the manuscript; and Xiaoli Li for secretarial help. We would
for cell type segregation and normal ultrastructure in pancreaticalso like to thank to former colleagues that contributed during the
islets. J. Cell Biol. 144, 325–337.early days of the “p135 project” including Miles Trupp, Ann-Sofie
Nilsson, Mike Fainzilber, Carina Raynoschek, Maria Elena Faxas, Garcia-Verdugo, J.M., Doetsch, F., Wichterle, H., Lim, D.A., and
Alvarez-Buylla, A. (1998). Architecture and cell types of the adultand To˜nis Timmusk. Financial support was obtained from the Swed-
ish Medical Research Council (33X-10908-10A), the Swedish Cancer subventricular zone: in search of the stem cells. J. Neurobiol. 36,
234–248.Society (3474-B97-05XBC), the Vth Framework Program of the Euro-
pean Union (QLG3-CT-2002-01000), and the Karolinska Institute. Gerlai, R., McNamara, A., Choi-Lundberg, D.L., Armanini, M., Ross,
G.P. was supported by the Wenner Gren Foundations and by the J., Powell-Braxton, L., and Phillips, H.S. (2001). Impaired water maze
Swedish Medical Research Council (33PS-14809-01A), and F.L. by learning performance without altered dopaminergic function in mice
the David och Astrid Hagele´ns Foundation. heterozygous for the GDNF mutation. Eur. J. Neurosci. 14, 1153–
1163.
Received: December 13, 2002
Holst, B.D., Vanderklish, P.W., Krushel, L.A., Zhou, W., Langdon,Revised: May 28, 2002
R.B., McWhirter, J.R., Edelman, G.M., and Crossin, K.L. (1998). Allo-Accepted: May 29, 2003
steric modulation of AMPA-type glutamate receptors increases ac-Published: June 26, 2003
tivity of the promoter for the neural cell adhesion molecule, N-CAM.
Proc. Natl. Acad. Sci. USA 95, 2597–2602.References
Jing, S.Q., Wen, D.Z., Yu, Y.B., Holst, P.L., Luo, Y., Fang, M., Tamir,
R., Antonio, L., Hu, Z., Cupples, R., et al. (1996). GDNF-inducedAiraksinen, M.S., Titievsky, A., and Saarma, M. (1999). GDNF family
neurotrophic factor signaling: four masters, one servant? Mol. Cell. activation of the ret protein tyrosine kinase is mediated by GDNFR-
alpha, a novel receptor for GDNF. Cell 85, 1113–1124.Neurosci. 13, 313–325.
Arenas, E., Trupp, M., A˚kerud, P., and Iba´n˜ez, C.F. (1995). GDNF Klein, R.D., Sherman, D., Ho, W.H., Stone, D., Bennett, G.L., Moffat,
prevents degeneration and promotes the phenotype of brain norad- B., Vandlen, R., Simmons, L., Gu, Q.M., Hongo, J.A., et al. (1997). A
renergic neurons in vivo. Neuron 15, 1465–1473. GPI-linked protein that interacts with ret to form a candidate neur-
turin receptor. Nature 387, 717–721.Baloh, R.H., Enomoto, H., Johnson, E.M., Jr., and Milbrandt, J.
(2000). The GDNF family ligands and receptors—implications for Klinz, S.G., Schachner, M., and Maness, P.F. (1995). L1 and N-CAM
neural development. Curr. Opin. Neurobiol. 10, 103–110. antibodies trigger protein phosphatase activity in growth cone-
enriched membranes. J. Neurochem. 65, 84–95.Beggs, H.E., Baragona, S.C., Hemperly, J.J., and Maness, P.F.
(1997). NCAM140 interacts with the focal adhesion kinase p125(fak) Kokaia, Z., Airaksinen, M.S., Nanobashvili, A., Larsson, E., Kujamaki,
and the SRC-related tyrosine kinase p59(fyn). J. Biol. Chem. 272, E., Lindvall, O., and Saarma, M. (1999). GDNF family ligands and
8310–8319. receptors are differentially regulated after brain insults in the rat.
Cacalano, G., Farinas, I., Wang, L.C., Hagler, K., Forgie, A., Moore, Eur. J. Neurosci. 11, 1202–1216.
M., Armanini, M., Phillips, H., Ryan, A.M., Reichardt, L.F., et al. (1998). Lois, C., Garcia-Verdugo, J.M., and Alvarez-Buylla, A. (1996). Chain
GFRalpha-1 is an essential receptor component for gdnf in the de- migration of neuronal precursors. Science 271, 978–981.
veloping nervous system and kidney. Neuron 21, 53–62.
Luthl, A., Laurent, J.P., Figurov, A., Muller, D., and Schachner, M.Chao, C.C., Ma, Y.L., Chu, K.Y., and Lee, E.H. (2003). Integrin alphav
(1994). Hippocampal long-term potentiation and neural cell adhe-and NCAM mediate the effects of GDNF on DA neuron survival,
sion molecules L1 and NCAM. Nature 372, 777–779.outgrowth, DA turnover and motor activity in rats. Neurobiol. Aging
Maness, P.F., Beggs, H.E., Klinz, S.G., and Morse, W.R. (1996).24, 105–116.
Selective neural cell adhesion molecule signaling by Src family tyro-Chazal, G., Durbec, P., Jankovski, A., Rougon, G., and Cremer, H.
sine kinases and tyrosine phosphatases. Perspect. Dev. Neurobiol.(2000). Consequences of neural cell adhesion molecule deficiency
4, 169–181.on cell migration in the rostral migratory stream of the mouse. J.
Neurosci. 20, 1446–1457. Moore, M.W., Klein, R.D., Farinas, I., Sauer, H., Armanini, M., Phillips,
H., Reichardt, L.F., Ryan, A.M., Carvermoore, K., and Rosenthal, A.Cremer, H., Lange, R., Christoph, A., Plomann, M., Vopper, G., Roes,
(1996). Renal and neuronal abnormalities in mice lacking gdnf. Na-J., Brown, R., Baldwin, S., Kraemer, P., Scheff, S., et al. (1994).
ture 382, 76–79.Inactivation of the N-CAM gene in mice results in size reduction
of the olfactory bulb and deficits in spatial learning. Nature 367, Muller, D., Wang, C., Skibo, G., Toni, N., Cremer, H., Calaora, V.,
455–459. Rougon, G., and Kiss, J.Z. (1996). PSA-NCAM is required for activity-
induced synaptic plasticity. Neuron 17, 413–422.Cremer, H., Chazal, G., Lledo, P.M., Rougon, G., Montaron, M.F.,
Mayo, W., Le Moal, M., and Abrous, D.N. (2000). PSA-NCAM: an Nanobashvili, A., Airaksinen, M.S., Kokaia, M., Rossi, J., Asztely, F.,
important regulator of hippocampal plasticity. Int. J. Dev. Neurosci. Olofsdotter, K., Mohapel, P., Saarma, M., Lindvall, O., and Kokaia,
18, 213–220. Z. (2000). Development and persistence of kindling epilepsy are
impaired in mice lacking glial cell line-derived neurotrophic factorCrossin, K.L., and Krushel, L.A. (2000). Cellular signaling by neural
cell adhesion molecules of the immunoglobulin superfamily. Dev. family receptor alpha 2. Proc. Natl. Acad. Sci. USA 97, 12312–12317.
Dyn. 218, 260–279. Niethammer, P., Delling, M., Sytnyk, V., Dityatev, A., Fukami, K., and
Doherty, P., and Walsh, F.S. (1994). Signal transduction events un- Schachner, M. (2002). Cosignaling of NCAM via lipid rafts and the
derlying neurite outgrowth stimulated by cell adhesion molecules. FGF receptor is required for neuritogenesis. J. Cell Biol. 157,
Curr. Opin. Neurobiol. 4, 49–55. 521–532.
Doherty, P., and Walsh, F.S. (1996). CAM-FGF Receptor Interactions: Paratcha, G., Ledda, F., Baars, L., Coulpier, M., Besset, V., Anders,
a model for axonal growth. Mol. Cell. Neurosci. 8, 99–111. J., Scott, R., and Iba´n˜ez, C.F. (2001). Released GFR alpha 1 potenti-
ates downstream signaling, neuronal survival, and differentiation viaDoherty, P., Fazeli, M.S., and Walsh, F.S. (1995). The neural cell
NCAM Is a Signaling Receptor for GDNF
879
a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29, Trupp, M., Scott, R., Whittemore, S.R., and Iba´n˜ez, C.F. (1999). Ret-
dependent and -independent mechanisms of GDNF signalling in171–184.
neuronal cells. J. Biol. Chem. 274, 20885–20894.Pichel, J.G., Shen, L.Y., Sheng, H.Z., Granholm, A.C., Drago, J.,
Williams, E.J., Furness, J., Walsh, F.S., and Doherty, P. (1994). Acti-Grinberg, A., Lee, E.J., Huang, S.P., Saarma, M., Hoffer, B.J., et al.
vation of the FGF receptor underlies neurite outgrowth stimulated(1996). Defects in enteric innervation and kidney development in
L1, N-CAM, and N-cadherin. Neuron 13, 583–594.mice lacking gdnf. Nature 382, 73–76.
Yu, T., Scully, S., Yu, Y.B., Fox, G.M., Jing, S.Q., and Zhou, R.P.Polo-Parada, L., Bose, C.M., and Landmesser, L.T. (2001). Alter-
(1998). Expression of GDNF family receptor components during de-ations in transmission, vesicle dynamics, and transmitter release
velopment—implications in the mechanisms of interaction. J. Neu-machinery at NCAM-deficient neuromuscular junctions. Neuron 32,
rosci. 18, 4684–4696.815–828.
Poteryaev, D., Titievsky, A., Sun, Y.F., Thomas-Crusells, J., Lindahl,
M., Billaud, M., Arumae, U., and Saarma, M. (1999). GDNF triggers
a novel Ret-independent Src kinase family-coupled signaling via a
GPI-linked GDNF receptor alpha 1. FEBS Lett. 463, 63–66.
Ronn, L.C., Berezin, V., and Bock, E. (2000). The neural cell adhesion
molecule in synaptic plasticity and ageing. Int. J. Dev. Neurosci. 18,
193–199.
Saffell, J.L., Doherty, P., Tiveron, M.C., Morris, R.J., and Walsh, F.S.
(1995). NCAM requires a cytoplasmic domain to function as a neurite
outgrowth-promoting neuronal receptor. Mol. Cell. Neurosci. 6,
521–531.
Saffell, J.L., Williams, E.J., Mason, I.J., Walsh, F.S., and Doherty, P.
(1997). Expression of a dominant negative FGF receptor inhibits
axonal growth and FGF receptor phosphorylation stimulated by
CAMs. Neuron 18, 231–242.
Sa´nchez, M.P., Silossantiago, I., Frisen, J., He, B., Lira, S.A., and
Barbacid, M. (1996). Renal agenesis and the absence of enteric
neurons in mice lacking GDNF. Nature 382, 70–73.
Schachner, M. (1997). Neural recognition molecules and synaptic
plasticity. Curr. Opin. Cell Biol. 9, 627–634.
Schuchardt, A., D’Agati, V., Larsson, B.L., Costantini, F., and
Pachnis, V. (1994). Defects in the kidney and enteric nervous system
of mice lacking the tyrosine kinase receptor Ret. Nature 367,
380–383.
Stork, O., Welzl, H., Cremer, H., and Schachner, M. (1997). Increased
intermale aggression and neuroendocrine response in mice defi-
cient for the neural cell adhesion molecule (NCAM). Eur. J. Neurosci.
9, 1117–1125.
Tansey, M.G., Baloh, R.H., Milbrandt, J., and Johnson, E.M. (2000).
GFR-mediated localization of RET to lipid rafts is required for effec-
tive downstream signaling, differentiation, and neuronal survival.
Neuron 25, 611–623.
Thomaidou, D., Coquillat, D., Meintanis, S., Noda, M., Rougon, G.,
and Matsas, R. (2001). Soluble forms of NCAM and F3 neuronal cell
adhesion molecules promote Schwann cell migration: identification
of protein tyrosine phosphatases zeta/beta as the putative F3 recep-
tors on Schwann cells. J. Neurochem. 78, 767–778.
Tomasiewicz, H., Ono, K., Yee, D., Thompson, C., Goridis, C., Rutis-
hauser, U., and Magnuson, T. (1993). Genetic deletion of a neural cell
adhesion molecule variant (N-CAM-180) produces distinct defects in
the central nervous system. Neuron 11, 1163–1174.
Treanor, J., Goodman, L., Desauvage, F., Stone, D.M., Poulsen, K.T.,
Beck, C.D., Gray, C., Armanini, M.P., Pollock, R.A., Hefti, F., et al.
(1996). Characterization of a multicomponent receptor for GDNF.
Nature 382, 80–83.
Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.-S., Sieber, B.A.,
Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Aruma¨e,
U., et al. (1996). Functional receptor for glial cell line-derived neuro-
trophic factor encoded by the c-ret proto-oncogene product. Nature
381, 785–789.
Trupp, M., Belluardo, N., Funakoshi, H., and Iba´n˜ez, C.F. (1997).
Complementary and overlapping expression of glial cell line-derived
neurotrophic factor (GDNF), c-ret proto-oncogene, and gdnf recep-
tor-alpha indicates multiple mechanisms of trophic actions in the
adult rat CNS. J. Neurosci. 17, 3554–3567.
Trupp, M., Raynoschek, C., Belluardo, N., and Iba´n˜ez, C.F. (1998).
Multiple GPI-anchored receptors control GDNF-dependent and in-
dependent activation of the c-Ret receptor tyrosine kinase. Mol.
Cell. Neurosci. 11, 47–63.
